GLLife and health insurance
Globe Life
- Price
- $151.66
- Intrinsic value
- Intrinsic value from an AI estimate
- Discount category
- Below intrinsic value (AI estimate)
- Analysts
- Leaning bullish
- Next earnings
- Jan 21 · · estimated
- Pick status
- Research only
In short
- Thesis
- The market doubts Globe Life after the short seller reports, the class action and new health losses at United American, and 2027 earnings within its guidance with lower health losses can lift its value.
- Gap
- Can close. The Q4 2026 results and 2027 results show if losses at United American stop and if Globe Life meets its 2027 guidance, and the class action can end with a ruling or a settlement.
Company guidance: 2027 net operating income per share of $16.10 to $17.10; 2026 of $15.35 to $15.65; 2026 buybacks of $725 to $775 million (, Q3 2026 earnings release (8-K))
Price history
About
Globe Life Inc. (GL) sells basic life insurance and supplemental health insurance to middle-income families in the United States. It sells through exclusive agencies: American Income Life, which focuses on union and credit union members, Liberty National and Family Heritage. It also sells directly to consumers by mail, phone and online, and through the independent United American agency, which sells Medicare Supplement and, through Evry Health, group health insurance.
Life insurance was 66% of premium revenue and 80% of the insurance underwriting margin in Q3 2026. Total premium was $3.88 billion in the first nine months of 2026. Globe Life reports in US dollars, and its shares trade on the NYSE.
Thesis
The market prices Globe Life with doubt since April 2024, when short seller reports made claims about the practices of its agencies. A securities class action and several shareholder derivative suits, which come in part from those reports, are still open, and the plaintiffs moved for class certification in May 2026. In Q3 2026, losses at Evry Health and a claims processing delay at the Centers for Medicare and Medicaid Services also caused an underwriting loss at United American, and Globe Life cut its 2026 guidance. The AI estimate uses a multiple of the 2027 net operating income per share that the company guides to.
For the price to rise, three things must be true. Globe Life must earn 2027 net operating income per share within its guidance of $16.10 to $17.10. United American must return to an underwriting profit as Evry raises prices and selects risks more carefully. The class action and the derivative suits must end without a large payment.
The Q4 2026 results, expected about January 21, 2027, are the next test, and the 2027 results show the trend over the next four quarters. If health losses grow, agent counts fall or a court rules against the company, the price can fall.
Valuation
AI estimate, checked by Kevin. How it is made
Show the method
The intrinsic value for Globe Life is an AI estimate from November 14, 2026. It is not an analyst's value. An AI research agent calculated it from the filings of Globe Life. The method is a multiple of net operating income per diluted share for 2027.
Net operating income is the company's own measure. It leaves out realized investment gains and losses, legal proceedings and some other items, and it is after interest, stock compensation and tax. The Q3 2026 results (Form 8-K of October 21, 2026) give net operating income of $4.84 per diluted share for Q3 2026, which includes a gain of $120.5 million before tax from the annual update of reserve assumptions. The Q1 and Q2 2026 results give $3.43 and $3.61 per share, so the first nine months were $11.88 per share.
The Q3 2026 results give 2026 guidance of $15.35 to $15.65 per share and 2027 guidance of $16.10 to $17.10 per share. They also give book value per share without accumulated other comprehensive income of $103.62 at September 30, 2026. Because net operating income is after interest, the estimate makes no separate debt adjustment. The Form 10-Q gives debt with a par value of $3,019 million at September 30, 2026.
The cover of the Form 10-Q gives 75,439,736 shares of common stock at October 30, 2026, and the estimate uses the per diluted share figures of the company. The 2027 net operating income per share and the multiples are assumptions. The low case assumes $15.60 per share, below the guidance, because losses at United American continue and lapses rise, at 8 times. It gives $124.80 per share.
The base case assumes $16.50, near the middle of the guidance, at 10.5 times. It gives $173.25 per share. The high case assumes $17.10, the top of the guidance, at 12 times. It gives $205.20 per share.
The estimate assumes weights of 25%, 50% and 25%. The weighted intrinsic value is $169.13 per share. Globe Life sells small basic life and supplemental health policies to middle-income families through its own exclusive agencies and by direct mail and online. Its life underwriting margin was 53% of premium in Q3 2026, and the company has kept high margins for many years.
Its agency systems are costly to build, and its policies stay in force for many years. These give an advantage that can last 10 years or more. But other insurers can sell similar policies, and the company must recruit new agents all the time. The estimate uses no results after September 30, 2026.
Checkpoints
- Jan 21, 2027 · est.PendingQ4 2026 results: health margins and 2026 earningsNet operating income for 2026 is within $15.35 to $15.65 per share and United American has an underwriting profit in Q4 2026, and this passes; a lower result or another underwriting loss fails.
- 2027 · est.PendingSecurities class actionThe court denies class certification or the case ends without a material payment, and this passes; class certification or a large settlement fails.
Recent events
- November 4, 2026The Board adopted amended by-laws. The lead independent director can now call special meetings of the Board, and the Compensation Committee now sets the pay only of executive officers.
- October 21, 2026Globe Life reported Q3 2026 results. Net operating income was $4.84 per diluted share, against $4.81 a year earlier, and total premium grew 7%. United American had an underwriting loss because of high-severity claims at Evry and a claims processing delay at the Centers for Medicare and Medicaid Services. Globe Life lowered its 2026 guidance to $15.35 to $15.65 per share and gave 2027 guidance of $16.10 to $17.10 per share.
- August 6, 2026Globe Life raised its quarterly dividend by 22% to $0.33 per share, and the Board authorized up to $2.5 billion under the share repurchase program.
Show 4 older eventsHide older events
- July 22, 2026Globe Life reported Q2 2026 results. Net operating income was $3.61 per diluted share, 10% more than a year earlier, and it raised its 2026 guidance to $15.55 to $15.95 per share.
- June 26, 2026Globe Life amended its $1 billion credit facility, which now matures in 2031, and increased its term loan from $250 million to $450 million, with maturity extended to June 2029.
- April 22, 2026Globe Life reported Q1 2026 results. Net operating income was $3.43 per diluted share, 12% more than a year earlier, and it raised its 2026 guidance to $15.40 to $15.90 per share.
- February 4, 2026Globe Life reported 2025 results. Net operating income was $14.52 per diluted share, against $12.37 in 2024.
Latest news and filings
- Last earnings
- October 21, 2026 (8-K on sec.gov)
- Next earnings
- Expected about January 21, 2027. The company has not confirmed the date.
- 8-KChange to shareholder rights or bylawsFiled gl-20261105
- 10-QQuarterly report for the period ended Sep 30, 2026Filed gl-20260930
- 8-KEarnings releaseFiled Press release and exhibits
- 8-KChange of directors or officersFiled gl-20260807
- 10-QQuarterly report for the period ended Jun 30, 2026Filed gl-20260630
- 8-KEarnings releaseFiled Press release and exhibits
- 8-KNew material agreementFiled gl-20260629
- 10-QQuarterly report for the period ended Mar 31, 2026Filed gl-20260331
- 8-KChange of directors or officers and Shareholder vote resultsFiled gl-20260504
- 8-KEarnings releaseFiled Press release and exhibits
Risks
- A securities class action for the period from May 2019 to April 2024 and several shareholder derivative suits are open. They come in part from short seller reports about the agencies. The plaintiffs moved for class certification in May 2026, and the company cannot estimate the amount of a loss.
- Evry Health, a young group health business, caused an underwriting loss of $26 million in the first nine months of 2026, and its results can stay volatile while it grows.
- Growth depends on the number of agents. The average producing agent count at American Income fell 7% in Q3 2026 from a year earlier.
- Medicare Supplement claims and medical cost trends are rising, and the company needs regulators to approve premium rate increases on health policies.
- Changes in interest rates move the fair value of the bond portfolio, which had a net unrealized loss of $2,687 million at September 30, 2026, and change the yield on new investments.
Key statistics
- Market cap
- $11B
- Shares of Oct 30, 2026
- Yield at current rate
- 0.9%
- Current annual rate, at the price of Nov 20, 2026
- Dividend yield
- 0.8%
- Last 12 months, at the price of Nov 20, 2026
- P/E (trailing)
- 10.2
- Price of Nov 20, 2026
- EPS (trailing)
- $14.94
- 12 months to Sep 30, 2026
- 52-week range
- $129.21 – $191.55
- To Nov 13, 2026
- Beta
- 0.47
- Vs S&P 500, 5 years monthly, to Oct 30, 2026
- Average volume
- 501K
- 3 months, to Nov 13, 2026
Check the numbers:ExchangeGoogle FinanceYahoo FinanceSEC filings
Balance sheet
- Cash
- $353M
- Debt
- $3.0B
- Net debt
- $2.7B
Cash against debt
debt covered by cashnet debt $2.7B
When the debt is due
The last debt is due in 2061.
At September 30, 2026, Globe Life had cash and short-term investments of $353 million and total debt with a par value of $3,019 million. Long-term debt was $2,700 million: senior notes due 2028 to 2034, junior subordinated debentures due 2057 and 2061, and a $450 million term loan due 2029. Short-term debt was $309 million of commercial paper and $10 million of Federal Home Loan Bank borrowings. The $1 billion credit facility, which backs the commercial paper, matures in June 2031 and was not drawn. Globe Life also has a $500 million pre-capitalized trust securities facility that lets it issue senior notes when it chooses. Shareholders' equity was $6,618 million, or $8,035 million without accumulated other comprehensive income. The insurance subsidiaries had $19.6 billion of investments, of which 86% were fixed maturities, and 97% of fixed maturities were investment grade.
Dividends
- Yield at the current rate
- 0.9% (current annual rate, at today’s price)
- Dividend yield
- 0.8% (last 12 months, at today’s price of $151.66)
- Paid per share
- $1.26 in the last 12 months (4 payments)
- Current annual rate
- $1.32 ($0.33 × 4 a year)
- Payout ratio
- 7% of the last fiscal year’s earnings (the year that ended December 31, 2025)
- Latest ex-dividend date
- October 5, 2026, $0.33 per share
Dividends per share by year
| 2016 | $0.555 | |
|---|---|---|
| 2017 | $0.59 | |
| 2018 | $0.63 | |
| 2019 | $0.679 | |
| 2020 | $0.737 | |
| 2021 | $0.782 | |
| 2022 | $0.822 | |
| 2023 | $0.883 | |
| 2024 | $0.945 | |
| 2025 | $1.05 |
From 2020 to 2025, the dividend grew by about 7.3% a year. From 2016 to 2025, the dividend grew by about 7.3% a year.
Source: company filings and market data, read on November 13, 2026. The ex-dividend date is the first day a buyer no longer gets the next payment.
Questions about Globe Life
What does Globe Life do?
Globe Life Inc. (GL) sells basic life insurance and supplemental health insurance to middle-income families in the United States. It sells through exclusive agencies: American Income Life, which focuses on union and credit union members, Liberty National and Family Heritage. Its market cap is $11B at the current price of $151.66.
When does Globe Life report earnings next?
This is an estimate: Globe Life may report on January 21, 2027. It last reported results on October 21, 2026.
Is Globe Life stock below its intrinsic value?
Globe Life stock is below intrinsic value. The source of the intrinsic value is: AI estimate. This is general information, not advice.
What changed recently at Globe Life?
The latest update is from November 4, 2026. The Board adopted amended by-laws.
What are the main risks for Globe Life?
A securities class action for the period from May 2019 to April 2024 and several shareholder derivative suits are open. Evry Health, a young group health business, caused an underwriting loss of $26 million in the first nine months of 2026, and its results can stay volatile while it grows. Growth depends on the number of agents.
How much debt and cash does Globe Life have?
At September 30, 2026, Globe Life had $3.0B of debt and $353M of cash.
Does Globe Life pay a dividend?
Yes. The current annual dividend of Globe Life is $1.32 per share. That is a dividend yield of 0.9% at the current price of $151.66. In the last 12 months, it paid $1.26 per share (0.8%). The latest ex-dividend date was October 5, 2026.
Similar companies
- COOThe Cooper CompaniesShares: Regulation and courts, Weak consumer
- Intrinsic value
- Below intrinsic value
- Gap
- Can close
- ABEVAmbevShares: Regulation and courts, Weak consumer
- Intrinsic value
- Well below intrinsic value
- Gap
- Can close
- AXPAmerican ExpressShares: Regulation and courts, Weak consumer
- Intrinsic value
- Below intrinsic value
- Gap
- Can close
- ULUnileverShares: Regulation and courts, Weak consumer
- Intrinsic value
- Close to intrinsic value
- Gap
- Can close
- ABGAsbury AutomotiveShares: Weak consumer, Regulation and courts
- Intrinsic value
- Well below intrinsic value
- Gap
- Can close
Loading your notes…
Read it all? Star GL or pass, then go on to the next one.